- Presbyopia, or age-related blurry near vision, is a common, progressive condition that reduces the eye's ability to focus on near objects and affects nearly half of the U.S. adult population, ...

Vuity (pilocarpine hydrochloride) is a prescription drug that’s used to treat blurry vision. The drug comes as an eye drop. It’s usually given once per day. Vuity is used in adults to treat presbyopia ...

Please provide your email address to receive an email when new articles are posted on . Vuity has been available for more than a year, in which time we have learned a lot about this modality for ...

It’s one of the more irritating side effects of aging: blurred close-up vision, or presbyopia. But a novel therapy, eyedrops that can improve near vision for hours, may help those who’ve gotten tired ...

Please provide your email address to receive an email when new articles are posted on . A second dose of Vuity 3 to 6 hours after the first dose may extend the effect for up to 9 hours. The most ...

Vuity contracts the iris sphincter muscle, constricting the pupil to improve near and intermediate visual acuity. The Food and Drug Administration (FDA) has approved the supplemental New Drug ...

A newly approved eye drop hitting the market on Thursday could change the lives of millions of Americans with age-related blurred near vision, a condition affecting mostly people 40 and older. Vuity, ...

About a year ago, the U.S. Food and Drug Administration authorized the first eye drop that could be used to improve the vision of people with a condition called presbyopia — the term doctors use for ...

For patients with presbyopia, or age-related blurry near vision, wearing glasses or contact lens has long been the mainstay correction method. Thanks to a new FDA approval, they now have an eye drop ...

SAN FRANCISCO (KGO) -- New eye drops can limit the use for reading glasses. Vuity has just been approved by the Food and Drug Administration, and local ophthalmologists say it can be a life-changer.

The first FDA-approved eye drops to treat age-related blurry near vision (presbyopia) has gone on sale in the US, offering a potential alternative to reading glasses for the estimated 128 million ...